Agenus Inc (NQ: AGEN )
3.420
USD
-0.140
(-3.93%)
Official Closing Price
Updated: 7:54 PM EST, Jan 21, 2021
Add to My Watchlist
Press releases about Agenus Inc
Completion of Balstilimab BLA Filing Extended To 1H2021
December 03, 2020
Agenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference
November 25, 2020
XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement
November 11, 2020
Dr. Steven O’Day Named Agenus Chief Medical Officer
November 05, 2020
Agenus Doses First COVID-19 Patient with iNKT Cell Therapy
November 02, 2020
Agenus R&D Update & Third Quarter Financial Report
October 29, 2020
Agenus to Report Third Quarter Earnings
October 20, 2020
Agenus to Present on Seven Novel Programs at SITC 2020
October 14, 2020
Susan Hirsch Joins Agenus’ Board of Directors
October 13, 2020
Agenus Presents Results from Two Large Cervical Cancer Trials at ESMO
September 18, 2020
Thinking about buying stock in Avinger, Vascular Biogenics, Intra-Cellular Therapies, Agenus, or Co-Diagnostics?
September 11, 2020
From PR Newswire
Paul Clark Joins Agenus Board of Directors
August 31, 2020
From PR Newswire
From PR Newswire
Agenus Provides R&D Update & Second Quarter Financial Report
August 06, 2020
From PR Newswire
US Stocks That Surged Higher This Week: $AMRN $NAK $AGEN
August 05, 2020
Tags
The Market Signal
From The Market Signal
Agenus to Present on Targeting Myeloid Cells in Tumor Microenvironment at the William Blair Biotech Focus 2020 Conference
August 04, 2020
From PR Newswire
Agenus R&D update & Second Quarter Earnings Report
July 29, 2020
From PR Newswire
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.